These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study. Sharpe MD; Ghent C; Grant D; Horbay GL; McDougal J; David Colby W Transplantation; 2003 Sep; 76(6):977-83. PubMed ID: 14508365 [TBL] [Abstract][Full Text] [Related]
4. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients. Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598 [TBL] [Abstract][Full Text] [Related]
5. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation. Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954 [TBL] [Abstract][Full Text] [Related]
6. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation. Shah T; Lai WK; Gow P; Leeming J; Mutimer D Transpl Infect Dis; 2005; 7(3-4):126-32. PubMed ID: 16390401 [TBL] [Abstract][Full Text] [Related]
7. Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients. Reed A; Herndon JB; Ersoz N; Fujikawa T; Schain D; Lipori P; Hemming A; Li Q; Shenkman E; Vogel B Liver Transpl; 2007 Dec; 13(12):1743-50. PubMed ID: 18044769 [TBL] [Abstract][Full Text] [Related]
8. [Prevention and treatment of fungal infections in solid-organ transplant recipients]. Muñoz P; Bouza E Rev Clin Esp; 1995 Oct; 195 Suppl 3():38-48. PubMed ID: 9441304 [No Abstract] [Full Text] [Related]
9. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome. Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369 [TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients. Winston DJ; Busuttil RW Transplantation; 2002 Sep; 74(5):688-95. PubMed ID: 12352887 [TBL] [Abstract][Full Text] [Related]
11. Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole. Hayes D; Ball AM; Mansour HM; Martin CA; Flynn JD Exp Clin Transplant; 2011 Dec; 9(6):399-404. PubMed ID: 22142048 [TBL] [Abstract][Full Text] [Related]
12. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H; J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606 [TBL] [Abstract][Full Text] [Related]
13. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients. Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782 [TBL] [Abstract][Full Text] [Related]
14. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation. Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683 [TBL] [Abstract][Full Text] [Related]
15. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Cuellar-Rodriguez J; Avery RK; Lard M; Budev M; Gordon SM; Shrestha NK; van Duin D; Oethinger M; Mawhorter SD Clin Infect Dis; 2009 Sep; 49(5):710-6. PubMed ID: 19635026 [TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of aspergillosis in orthotopic liver transplant recipients]. Liu ZW; Zou WL; Zhu XD; Zhang XL; Liu Y; Shen ZY Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):171-4. PubMed ID: 15760547 [TBL] [Abstract][Full Text] [Related]
17. The successful treatment of mycotic infections in immunosuppressed renal transplant recipients with ketoconazole. Zazgornik J; Marosi L; Kopsa H; Schmidt P; Balcke P; Zyman H; Thurner J Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):268-70. PubMed ID: 6286515 [TBL] [Abstract][Full Text] [Related]
18. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy. Grigull L; Kuehlke O; Beilken A; Sander A; Linderkamp C; Schmid H; Seidemann K; Sykora KW; Schuster FR; Welte K Pediatr Transplant; 2007 May; 11(3):261-6. PubMed ID: 17430480 [TBL] [Abstract][Full Text] [Related]